Schedule 13D ownership disclosure
INOZYME PHARMA INC
Security class unavailable · CUSIP: 45790W108
Event date: 2020-07-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,028,308
- Percent of class
- 8.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-031808
- Form type
- SC 13D
- Filer
- Inozyme Pharma, Inc.
- CIK
- CIK 1693011
- Filed
- Mar 04, 2021
- Reporting period
- Jul 28, 2020
- Description
- Schedule 13D beneficial ownership